PMC Isochem

Abstract Insufficient aqueous dissolution properties constitute a fundamental barrier impacting approximately 40% of commercialized and 90% developmental pharmaceuticals, significantly limiting...

Abstract Colorectal cancer (CRC) continues to be a foremost human health concern globally, with chemotherapy being the cornerstone of the...

This year, the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology takes place in Prague, Czech Republic.   From...

Abstract Therapeutic agents approved for the topical treatment of dermatological diseases have diverse physicochemical properties, but they are frequently poorly...

This year DCAT Week opens its doors in New York City. From 23th to 26th March the DCAT Week 2026...

Abstract The aim of this study was to develop a once-daily controlled-release (CR) apixaban (APX) formulation that enhances bioavailability through...

Abstract Poor aqueous solubility and thereby poor and/or variable bioavailability of drug candidates is frequently overcome by developing enabling formulations...

Abstract A d-α-Tocopheryl Polyethylene Glycol-1000 Succinate (TPGS)-functionalized nanoparticle formulation was developed for the co-delivery of Paclitaxel (PTX) and Gefitinib (GEF)...

PMC Isochem, have developed four Vitamin E TPGS premixes ( see the brochure below) with 4 common excipients used as...

Abstract Ezetimibe is a cholesterol absorption inhibitor widely used in the treatment of dyslipidemia. However, its clinical efficacy is limited...